ISIrina Veniaminovna Stagnieva

Irina Veniaminovna Stagnieva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irina Veniaminovna Stagnieva has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Endotypes of chronic rhinosinusitis and adenoiditis in children associated with hypertrophy of the pharyngeal lymphoepithelial ring

    by Irina V. Stagnieva, Daria O. Zatulivetrova, Stanislav D. Stagniev

    BACKGROUND: The high prevalence of chronic adenoiditis and chronic rhinosinusitis in children, their shared pathogenetic pathways, and the absence of a unified concept of upper airway inflammation necessitate new diagnostic approaches. Current clinical and morphological criteria do not account for underlying molecular mechanisms, which limits personalized therapy and calls for endotyping of chronic inflammation. AIM: To determine the endotypes of chronic inflammation in children with chronic rhinosinusitis and adenoiditis associated with hypertrophy of the pharyngeal lymphoepithelial ring. METHODS: A prospective cohort study was performed at ENT departments in Rostov-on-Don from 2022 to 2024. The study involved 90 children aged 3–15 years with pharyngeal tonsil hypertrophy, divided into a chronic adenoiditis group (n = 45) and a chronic rhinosinusitis group (n = 45). The control group comprised 30 healthy children. All participants underwent an otorhinolaryngological examination and spiral computed tomography of the paranasal sinuses. Endotyping was performed by measuring 12 markers (IFN-γ, TNF-α, IL-5, IL-17α, IL-6, IL-8, IL-33, IL-35, IL-22, TGF-β1, MPO, IgE) in serum (ELISA) and in excised tonsil tissue (immunohistochemistry, H-score). Statistical analysis included cluster analysis, Wilks' lambda test, Fisher's F-test, and the chi-square test with Yates' correction. RESULTS: Cluster analysis identified three endotypes. The differentially significant markers were IFN-γ, TNF-α, IL-5, TGF-β1, IL-33, and IL-35 (p 0.0001). Based on serum data, the Th1 endotype was identified in 18.9% (17/90), the Th2 endotype in 26.7% (24/90), and the Treg endotype in 54.4% (49/90) of patients. Contingency analysis of systemic and local parameters confirmed cluster validity (χ²(Yates) = 328.4; p 0.0001; contingency coefficient = 0.86). The Treg endotype is characterized by the highest serum levels of TGF-β1 (F = 657.3; p 0.0001) and IL-35 (F = 487.2; p 0.0001) and their hyperexpression in tissue (TGF-β1: 123–250 points, IL-35: 98–231 points), which is associated with antigenic stimulation and tissue remodeling. CONCLUSION: Three endotypes of chronic inflammation were identified in children with chronic rhinosinusitis and chronic adenoiditis with pharyngeal tonsil hypertrophy. The Treg endotype, found in the majority of patients (54.4%) , is associated with true lymphoid tissue hypertrophy. Determination of molecular markers of the inflammatory endotype provides a pathogenetic rationale for treatment. In particular, identification of the Treg endotype may serve as an additional indication for adenoidectomy.

  • Eosinophilic granulomatosis with polyangiitis

    by Irina V. Stagnieva, Daria O. Zatulivetrova

    Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic disease in the group of ANCA-associated vasculitides, characterized by a combination of severe eosinophilic asthma, chronic rhinosinusitis, hypereosinophilia, and necrotizing vasculitis of small and medium-sized vessels. The rationale for this review stems from the considerable delay in EGPA diagnosis, the heterogeneity of clinical phenotypes, and the emergence of new therapeutic targets, which necessitates a synthesis of current data for practicing physicians. Based on the analysis of modern international consensus statements and scientific publications, the review systematizes data on the epidemiology, etiopathogenesis, classification, and clinical manifestations of EGPA. Particular attention is paid to the role of the cytokine profile (Th2, IL-5) and genetic predisposition in the formation of distinct disease endotypes (ANCA-positive and ANCA-negative), which determine disease course and response to therapy. The new 2022 ACR/EULAR classification criteria with high sensitivity and specificity are discussed in detail. The treatment section analyzes the evolution of therapeutic approaches: from standard immunosuppressive therapy with glucocorticoids and cyclophosphamide to modern targeted biological drugs, such as mepolizumab (anti-IL-5) and rituximab. The conclusion emphasizes that despite improved survival, traditional therapy remains associated with high toxicity and frequent relapses, making the development of personalized strategies based on endotyping a key direction in the management of patients with EGPA.

  • Remodeling of sinuses’ walls in chronic rhinosinusitis with polyps according to computed tomography

    by N.V. Boiko, I.V. Stagnieva, O.E. Lodochkina, E.A. Pisarenko

    Tissue remodeling plays an important role among the many factors that determine the severe long course of chronic rhinosinusitis (CRS). Objective. To study the processes of bone remodeling according to computed tomography in CRS patients with polyps and severe long course of the disease. Patients and methods. A retrospective analysis of the results of spiral computed tomography (SCT) of patients with severe course of CRS with polyps was performed. The study group included 20 patients. The results of the SCT examination during initial presentation (at that time, the average duration of the disease was 10 years) were selected for analysis, as well as in dynamics: on average 34 and 84 months from the initial study. The control group consisted of 20 patients without inflammatory changes of the paranasal sinuses, who underwent SCT twice for different indications with an average interval of 32 months. Linear dimensions and bone density in Hounsfield units were determined in the analysis of SCT results. Results. Comparison of the initial indicators of the study and control groups has revealed a significant increase in the density of the intersinusal septums of the frontal and sphenoidal sinuses without a significant change in their thickness, as well as a significant increase in the density and thickness of the posterior walls of the maxillary sinuses. There were no differences in the transverse dimension of the ethmoidal sinus in the study and control groups. A progressive increase of the thickness of the posterior walls of the maxillary sinuses has been noted in repeated investigations. Conclusions. A progressive increase in the thickness of the sinuses’ walls and their density indicates the development of osteitis, which is one of the factors determining the long severe course of the disease.


  • Diagnostic algorithm for endotypes of chronic rhinosinusitis in children

    by I.V. Stagnieva, P.A. Stateshnaya, N.V. Boiko, S.D. Stagniev

    Most symptoms of chronic rhinosinusitis manifest in adulthood, in this connection it is not always possible to assume the endotype of the disease by phenotype in a child. An early identification of the disease’s endotype is necessary for optimization of diagnosis and choice of personalized management of children with chronic rhinosinusitis. Objective. To develop an algorithm for diagnosis of endotypes of chronic rhinosinusitis in children. Patients and methods. The study included 160 children diagnosed with «chronic rhinosinusitis». Inflammatory markers, namely IL-5, IFN-γ, IL-17α, TNF-α, IL-22, IL-6, IL-33, IL-35, ECP, MPO, TGF-β1, total IgE, were determined in the blood serum and nasal secretion by enzyme immunoassay. The endotypes of chronic rhinosinusitis were determined by cluster analysis. The coupling of the endotypes with the phenotypes of the disease was done and markers with high discriminant power for each endotype were identified. Results. After comparison of the coupling between phenotypes and all endotypes, it has been found that the phenotype of chronic rhinosinusitis with polyps and concurrent diseases (allergic rhinitis and bronchial asthma) has the Th-2 endotype by nasal secretion markers, but 3 different subendotypes by blood serum markers. The phenotype of chronic rhinosinusitis without polyps and concomitant pathology has the same set of markers in nasal secretion and in blood serum — Th-1 endotype. The phenotype of chronic rhinosinusitis associated with hypertrophy of the pharyngeal lymphatic ring has its own endotype with high degree of coupling. Conclusions. ECP and IL-33 are nasal secretion markers for the Th-2 endotype, IFN-γ is the Th-1 endotype marker, IL-35, MPO and TGF-β1 are markers for the endotype associated with hypertrophy of the pharyngeal lymphatic ring. The blood serum markers can be used for the identification of subendotypes of the Th-2 endotypes: IL-17 and IL-22 — for the subendotype of chronic rhinosinusitis with polyps, ECP — for the subendotype with allergic rhinitis, a decrease in the IL-35 level — for the subendotype with high risk of bronchial asthma development.


  • Endotypes of chronic rhinosinusitis in children

    by I.V. Stagnieva, P.A. Stateshnaya, N.V. Boiko, S.D. Stagniev

    Currently, there are no sensitive markers with sufficient specificity to diagnose endotypes of chronic rhinosinusitis in children which would allow to identify targets for biological therapy. OBJECTIVE To identify diagnostic biomarkers of chronic rhinosinusitis endotypes in children. PATIENTS AND METHODS The study included 160 children with chronic rhinosinusitis aged from 5 to 17 years, who were divided into five groups by disease’s phenotype: without polyps and comorbid background, with polyps, with allergic rhinitis, with bronchial asthma and with pharyngeal lymphoid ring hypertrophy. The control group consisted of 30 healthy children. All patients underwent a full clinical, endoscopic examination, computed tomography of sinuses and detection of inflammatory biomarkers in blood serum: IL-5, IFN-γ, IL-17α, TNF-α, IL-22; IL-6, IL-33, IL-35, eosinophil cationic peptide (ECP), myeloperoxidase (MPO), TGF-β1, total IgE. RESULTS A number of clusters equal 5 were identified by clustering method. Based on the association data between phenotypes and endotypes of chronic rhinosinusitis, 5 endotypes with significant association were identified (c2 (Yates)=270.6; p<0.0001). The two endotypes (without polyps and with hypertrophy of the pharyngeal lymphoid ring) had the greatest agreement with phenotype. Endotype ranking revealed diagnostically significant biomarkers. CONCLUSION Diagnostic serum biomarkers for endotype of rhinosinusitis with polyps are IL-17α, IL-22, TNF-α, IL-33 and a decrease in IL-35 level; for rhinosinusitis endotype in combination with allergic rhinitis — an increase in the levels of total IgE, IL-5 and ECP; for endotype of rhinosinusitis in combination with bronchial asthma — reduced IL-35 level; for endotype without polyps — increased levels of TGF-β1 and IFN-γ; for endotype in combination with pharyngeal lymphoid ring hypertrophy — increased levels of MPO, TGF-β1 and IL-35.


  • Case of spontaneous disappearance of maxillary sinus cyst

    by N.V. Boiko, I.V. Stagnieva

    Maxillary sinus retintiation cysts (MSRC) are relatively common revealed in the use of modern imaging techniques. The MSRC are asymptomatic and often regress spontaneously. Thus, when determining indications for surgical treatment of patients with MSRC, the presence of clinical manifestations, the cyst size, the probability of sinus fistula obturation and other circumstances in which the surgical intervention is quite justified, should be taken into account. A case of spontaneous disappearance of a maxillary sinus cyst identified in the patient 12 years ago is described in the article.

  • Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps

    by N.V. Boiko, I.V. Stagnieva, O.E. Lodochkina, N.V. Kurbatova

    Chronic rhinosinusitis (CRS) with nasal polyps is the most severe form of inflammatory diseases of the paranasal sinuses, especially in combination with comorbid asthma. A new avenue for the personalized treatment of severe forms of eosinophilic inflammation are biologics based on humanized monoclonal antibodies. Objective. To study the effectiveness of targeted therapy in patients with CRS with nasal polyps and comorbid asthma. Material and methods. 19 patients selected for biological therapy according to international criteria were studied. The patients were randomly divided into 2 groups. The first group included 10 patients treated with dupilumab. Dupilumab was administered subcutaneously 300 mg every 2 weeks for 24 weeks. Group 2 included 9 patients treated with reslizumab for severe eosinophilic asthma with comorbid CRS with nasal polyps. Reslizumab was administered intravenously 3 mg/kg body weight once every 4 weeks for 24 weeks. These patients constituted the comparison group. Both drugs are used in treatment of eosinophilic inflammation but have different biological targets. Results. Comparative analysis of the dynamics of the main indicators characterizing the clinical course of CRS with nasal polyps and asthma (SNOT-22, control of asthma symptoms — ACT, the results of SCT of the paranasal sinuses according to the Lund-Mackay score) revealed a positive trend in patients of both groups, more pronounced in patients receiving dupilumab. Conclusion. Changes in CT of the paranasal sinuses, characterized by the Lund-Mackay score, the results of SNOT-22 and ACT are the most demonstrative and can be used to assess the results of treatment with biologics in patients with chronic rhinosinusitis with nasal polyps.


  • Long-term use efficacy of medicine based on monoclonal antibodies in patient with asthma and comorbid rhinosinusitis with nasal polyps

    by N.V. Boiko, I.V. Stagnieva, O.E. Lodochkina, V.V. Kiselev, E.L. Gukasyan, P.A. Stateshnaya

    ЦЕЛЬ ИССЛЕДОВАНИЯ Представить особенности длительного лечения препаратом на основе моноклональных антител больного с тяжелой эозинофильной астмой и коморбидным хроническим риносинуситом с полипами. Представлено описание клинического наблюдения больного 56 лет, который течение 5 лет страдал тяжелой эозинофильной астмой и рецидивирующими назальными полипами. Пациент перенес 3 эндоназальных эндоскопических вмешательства по поводу полипозного риносинусита. В 2020 г. ему был начат курс лечения препаратом на основе моноклональных антител в дозе 3 мг/кг 1 раз в 4 нед. Контроль эффективности лечения препаратом осуществляли по стандартным опросникам оценки качества жизни SNOT-22 и теста Asthma Control Test, данным эндоскопии полости носа, спиральной компьютерной томографии околоносовых пазух, результатам анализа крови: общей эозинофилии, содержанию эозинофильного катионного протеина в крови. РЕЗУЛЬТАТЫ И ОБСУЖДЕНИЕ После 8 введений препарата (32 нед) у пациента улучшились показатели контроля астмы, но носовое дыхание оставалось затрудненным ввиду наличия обтурирующих полипов, в связи с чем ему была произведена эндоназальная эндоскопическая ревизия полости носа с удалением полипов, курс биологической терапии был продолжен. В послеоперационном периоде отмечено значительное улучшение показателей контроля астмы и уменьшение выраженности назальных симптомов (до начала лечения препаратом, после 8 введений препарата до операции, после 11 введений после операции): количество эозинофилов в 1 мл (%) — 700, 80, 100 соответственно; эозинофильный катионный протеин (нг/мл) — 37,8; 5,2; 5,4; оценка носового дыхания по шкале SNOT-22 (баллов) — 86, 52, 3; общий индекс полипов — 8, 8, 0; оценка результатов компьютерной томографии пазух по шкале Lund—Mackay (баллов) — 22, 20, 9; оценка контроля астмы по данным стандартного теста контроля астмы (баллов) — 11, 13, 25; ОФВ1 — 102, 106, 120%. ВЫВОДЫ Хирургическое вмешательство после 32 нед лечения, восстановившее носовое дыхание у пациента, привело к значительному улучшению показателей контроля астмы при дальнейшей терапии препаратом на основе моноклональных антител.


  • Peculiarities of fungal and bacterial microorganisms persistence in the structure of fungal balls of paranasal sinuses

    by N.V. Boiko, A.V. Gurov, I.V. Stagnieva, S.A. Bannikov

    Objective. To compare the data of pathomorphological and microbiological examination of fungal balls removed at paranasal sinuses endoscopic surgery. Material and methods. A total of 148 samples were obtained from patients histologically diagnosed with fungal balls. Microscopic evaluation of the specimens stained according to the Gram method, Gomori-Grocott method and PAS-reaction method, revealed phase changes in the fungal balls conditioned by their different life cycles: the areas of young, mature and degenerating mycelium were detected. Degeneration lead to detritus formation. Detritus areas contained accumulated bacterial colonies. The cultural study of the fungal balls removed from paranasal sinuses, showed fungi growth in 17.6% of cases, while the pathomorphological study confirmed presence of fungi in every investigated sample. Aerobic and anaerobic microbiota of the sinuses contents was represented by multi-agent bacterial and fungal-bacterial associations. Statistical analysis of contingency between culture-positive rate of fungi and different bacteria detected in clinical samples from fungal balls revealed inhibitory influence of Pseudomonas aeruginosa on fungi growth, which might be a reasons of their low isolation rate. Supposedly in some cases the fungal balls consisted of dead fungi, or the sampling was done in the area of the fungal balls degeneration, which might also account for the low sensibility of the cultural method.